168 related articles for article (PubMed ID: 11885848)
1. Minidose (1 mg) warfarin as prophylaxis for central vein catheter thrombosis.
Heaton DC; Han DY; Inder A
Intern Med J; 2002 Mar; 32(3):84-8. PubMed ID: 11885848
[TBL] [Abstract][Full Text] [Related]
2. Prophylaxis of central venous catheter-related thrombosis with minidose warfarin: analysis of its use in 427 cancer patients.
Magagnoli M; Masci G; Castagna L; Zucali PA; Morenghi E; Pedicini V; Santoro A
Anticancer Res; 2005; 25(4):3143-7. PubMed ID: 16080578
[TBL] [Abstract][Full Text] [Related]
3. Prophylaxis of central venous catheter-related thrombosis with minidose warfarin in patients treated with high-dose chemotherapy and peripheral-blood stem-cell transplantation: retrospective analysis of 228 cancer patients.
Magagnoli M; Masci G; Castagna L; Pedicini V; Poretti D; Morenghi E; Brambilla G; Santoro A
Am J Hematol; 2006 Jan; 81(1):1-4. PubMed ID: 16369969
[TBL] [Abstract][Full Text] [Related]
4. Low-molecular-weight heparin (nadroparin) and very low doses of warfarin in the prevention of upper extremity thrombosis in cancer patients with indwelling long-term central venous catheters: a pilot randomized trial.
Mismetti P; Mille D; Laporte S; Charlet V; Buchmüller-Cordier A; Jacquin JP; Fournel P; Dutrey-Dupagne C; Decousus H;
Haematologica; 2003 Jan; 88(1):67-73. PubMed ID: 12551829
[TBL] [Abstract][Full Text] [Related]
5. The use of low-dose warfarin as prophylaxis for central venous catheter thrombosis in patients with cancer: a meta-analysis.
Rawson KM; Newburn-Cook CV
Oncol Nurs Forum; 2007 Sep; 34(5):1037-43. PubMed ID: 17878131
[TBL] [Abstract][Full Text] [Related]
6. Prevention of central venous catheter associated thrombosis using minidose warfarin in patients with haematological malignancies.
Boraks P; Seale J; Price J; Bass G; Ethell M; Keeling D; Mahendra P; Baglin T; Marcus R
Br J Haematol; 1998 Jun; 101(3):483-6. PubMed ID: 9633891
[TBL] [Abstract][Full Text] [Related]
7. Warfarin and reduced central venous thrombosis in home total parenteral nutrition patients.
Veerabagu MP; Tuttle-Newhall J; Maliakkal R; Champagne C; Mascioli EA
Nutrition; 1995; 11(2):142-4. PubMed ID: 7647477
[TBL] [Abstract][Full Text] [Related]
8. Incidence, risk factors, and outcomes of catheter-related thrombosis in adult patients with cancer.
Lee AY; Levine MN; Butler G; Webb C; Costantini L; Gu C; Julian JA
J Clin Oncol; 2006 Mar; 24(9):1404-8. PubMed ID: 16549834
[TBL] [Abstract][Full Text] [Related]
9. Incidence of thrombotic complications in patients with haematological malignancies with central venous catheters: a prospective multicentre study.
Cortelezzi A; Moia M; Falanga A; Pogliani EM; Agnelli G; Bonizzoni E; Gussoni G; Barbui T; Mannucci PM;
Br J Haematol; 2005 Jun; 129(6):811-7. PubMed ID: 15953009
[TBL] [Abstract][Full Text] [Related]
10. [Is a three-month therapy with warfarin adequate for effective therapy of patients after an episode of venous thrombosis].
Vorob'eva NM; Ermolina OV; Balakhonova TV; Dobrovol'skiĭ AB; Titaeva EV; Kirienko AI; Panchenko EP
Ter Arkh; 2008; 80(7):50-4. PubMed ID: 18763596
[TBL] [Abstract][Full Text] [Related]
11. Low-dose warfarin for the prevention of central line-associated thromboses in children with malignancies--a randomized, controlled study.
Ruud E; Holmstrøm H; De Lange C; Hogstad EM; Wesenberg F
Acta Paediatr; 2006 Sep; 95(9):1053-9. PubMed ID: 16938749
[TBL] [Abstract][Full Text] [Related]
12. Systemic anticoagulant prophylaxis for central catheter-associated venous thrombosis in cancer patients.
Chan A; Iannucci A; Dager WE
Ann Pharmacother; 2007 Apr; 41(4):635-41. PubMed ID: 17355999
[TBL] [Abstract][Full Text] [Related]
13. Prevention of central venous catheter-associated thrombosis: a meta-analysis.
Kirkpatrick A; Rathbun S; Whitsett T; Raskob G
Am J Med; 2007 Oct; 120(10):901.e1-13. PubMed ID: 17904462
[TBL] [Abstract][Full Text] [Related]
14. Does warfarin safely prevent clotting of hemodialysis catheters? a review of efficacy and safety.
Willms L; Vercaigne LM
Semin Dial; 2008; 21(1):71-7. PubMed ID: 18251961
[TBL] [Abstract][Full Text] [Related]
15. Central venous device-related infection and thrombosis in patients treated with moderate dose continuous-infusion interleukin-2.
Eastman ME; Khorsand M; Maki DG; Williams EC; Kim K; Sondel PM; Schiller JH; Albertini MR
Cancer; 2001 Feb; 91(4):806-14. PubMed ID: 11241250
[TBL] [Abstract][Full Text] [Related]
16. A randomized, controlled trial of heparin versus placebo infusion to prolong the usability of peripherally placed percutaneous central venous catheters (PCVCs) in neonates: the HIP (Heparin Infusion for PCVC) study.
Shah PS; Kalyn A; Satodia P; Dunn MS; Parvez B; Daneman A; Salem S; Glanc P; Ohlsson A; Shah V
Pediatrics; 2007 Jan; 119(1):e284-91. PubMed ID: 17200252
[TBL] [Abstract][Full Text] [Related]
17. Low-dose warfarin does not decrease the rate of thrombosis in patients with cervix and vulvo-vaginal cancer treated with chemotherapy, radiation, and erythropoeitin.
Lin A; Ryu J; Harvey D; Sieracki B; Scudder S; Wun T
Gynecol Oncol; 2006 Jul; 102(1):98-102. PubMed ID: 16406065
[TBL] [Abstract][Full Text] [Related]
18. Thrombosis prophylaxis in cancer patients with a central venous catheter.
Laporte S; Decousus H; Mismetti P
Arch Intern Med; 2004 Feb; 164(4):459; author reply 459-60. PubMed ID: 14980999
[No Abstract] [Full Text] [Related]
19. A randomized trial of minidose warfarin for the prevention of late malfunction in tunneled, cuffed hemodialysis catheters.
Mokrzycki MH; Jean-Jerome K; Rush H; Zdunek MP; Rosenberg SO
Kidney Int; 2001 May; 59(5):1935-42. PubMed ID: 11318966
[TBL] [Abstract][Full Text] [Related]
20. A randomized trial comparing long-term and short-term use of umbilical venous catheters in premature infants with birth weights of less than 1251 grams.
Butler-O'Hara M; Buzzard CJ; Reubens L; McDermott MP; DiGrazio W; D'Angio CT
Pediatrics; 2006 Jul; 118(1):e25-35. PubMed ID: 16785289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
